These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
511 related items for PubMed ID: 19751376
1. Caffeine versus theophylline for apnea of prematurity: a randomised controlled trial. Skouroliakou M, Bacopoulou F, Markantonis SL. J Paediatr Child Health; 2009 Oct; 45(10):587-92. PubMed ID: 19751376 [Abstract] [Full Text] [Related]
2. Caffeine therapy for apnea of prematurity. Schmidt B, Roberts RS, Davis P, Doyle LW, Barrington KJ, Ohlsson A, Solimano A, Tin W, Caffeine for Apnea of Prematurity Trial Group. N Engl J Med; 2006 May 18; 354(20):2112-21. PubMed ID: 16707748 [Abstract] [Full Text] [Related]
3. [Therapeutic concentrations of theophylline and caffeine during treatment of apnea in premature infants with theophylline]. Alix D, Berthou F, Riche C, Gouedard H. Arch Fr Pediatr; 1985 May 18; 42(6):465-9. PubMed ID: 4051680 [Abstract] [Full Text] [Related]
7. Apnea of prematurity: theophylline v. caffeine. Harrison H. Alaska Med; 1992 May 18; 34(4):173-6. PubMed ID: 1288312 [Abstract] [Full Text] [Related]
8. Caffeine versus theophylline for apnea in preterm infants. Steer PA, Henderson-Smart DJ. Cochrane Database Syst Rev; 2000 May 18; (2):CD000273. PubMed ID: 10796190 [Abstract] [Full Text] [Related]
9. Caffeine versus theophylline for apnea in preterm infants. Henderson-Smart DJ, Steer PA. Cochrane Database Syst Rev; 2010 Jan 20; 2010(1):CD000273. PubMed ID: 20091506 [Abstract] [Full Text] [Related]
10. Serum caffeine concentrations in preterm neonates. Leon AE, Michienzi K, Ma CX, Hutchison AA. Am J Perinatol; 2007 Jan 20; 24(1):39-47. PubMed ID: 17195151 [Abstract] [Full Text] [Related]
11. A randomized controlled trial of theophylline versus CO2 inhalation for treating apnea of prematurity. Al-Saif S, Alvaro R, Manfreda J, Kwiatkowski K, Cates D, Qurashi M, Rigatto H. J Pediatr; 2008 Oct 20; 153(4):513-8. PubMed ID: 18534618 [Abstract] [Full Text] [Related]
12. Accuracy and reliability of dosing equations to individualize theophylline treatment of apnea of prematurity. Bhatt-Mehta V, Johnson CE, Donn SM, Spadoni V, Schork MA. Pharmacotherapy; 1995 Oct 20; 15(2):246-50. PubMed ID: 7624272 [Abstract] [Full Text] [Related]
14. Pharmacokinetics of theophylline and caffeine after intravenous administration of aminophylline to premature neonates in Korea. Ahn HW, Shin WG, Park KJ, Suh OK, Choi JH. Res Commun Mol Pathol Pharmacol; 1999 Oct 20; 105(1-2):105-13. PubMed ID: 10850374 [Abstract] [Full Text] [Related]
15. T4 levels in methylxanthine-treated premature newborns. Sourgens H, Staib AH, Bielicki M, von Loewenich V. Pediatr Pharmacol (New York); 1983 Oct 20; 3(3-4):267-72. PubMed ID: 6677876 [Abstract] [Full Text] [Related]
18. Use of methylxanthine therapies for the treatment and prevention of apnea of prematurity. Schoen K, Yu T, Stockmann C, Spigarelli MG, Sherwin CM. Paediatr Drugs; 2014 Apr 20; 16(2):169-77. PubMed ID: 24399614 [Abstract] [Full Text] [Related]